Key Events This Week
27 Apr: Stock opens at Rs.506.15, declines amid broader market gains
28 Apr: Intraday low hit at Rs.464.5 amid heavy price pressure
29 Apr: Bearish momentum confirmed with 7.51% drop to Rs.468.15
30 Apr: Intraday high of Rs.508.85 with 9.18% surge, closing at Rs.478.75

Rossari Biotech Ltd Surges 9.18% to Day's High of Rs 508.85 — Outperforms Sector by 7.53 Percentage Points
2026-04-30 14:01:02The Sensex declined by 0.38% on 30 Apr 2026, while Rossari Biotech Ltd surged 9.18%, outperforming its Specialty Chemicals sector by 7.53 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read full news article
Rossari Biotech Ltd Faces Technical Momentum Shift Amid Bearish Trends
2026-04-30 08:03:25Rossari Biotech Ltd, a specialty chemicals company, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s technical indicators reveal a nuanced picture that investors should carefully analyse amid a challenging market backdrop.
Read full news article
Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downturn
2026-04-29 08:03:52Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a marked shift in price momentum and technical indicators, signalling a deteriorating outlook. The stock’s recent 7.51% decline to ₹468.15, coupled with a downgrade in its Mojo Grade from Hold to Sell, reflects growing bearish sentiment among investors and analysts alike.
Read full news articleAre Rossari Biotech Ltd latest results good or bad?
2026-04-28 19:15:25Rossari Biotech Ltd's latest financial results for Q4 FY26 present a mixed picture. The company reported consolidated net sales of ₹684.86 crores, reflecting a sequential growth of 17.74% and an 18.17% increase year-on-year. This performance indicates resilience in revenue generation, although it represents a deceleration compared to the company's historical growth trajectory, which has averaged a five-year CAGR of 28.63%. On the profit side, consolidated net profit reached ₹45.97 crores, marking a significant sequential increase of 40.28% and a year-on-year growth of 33.48%. However, this profit surge was significantly bolstered by exceptional other income of ₹19.07 crores, raising questions about the sustainability of such earnings quality in future periods. Despite these positive headline figures, the operating margin (excluding other income) declined to 11.28%, down from 11.84% in the previous quart...
Read full news article
Rossari Biotech Ltd Hits Intraday Low Amid Price Pressure on 28 Apr 2026
2026-04-28 15:31:03Rossari Biotech Ltd experienced a significant intraday decline on 28 Apr 2026, touching a low of Rs 464.5, down 8.23% from previous levels. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure amid a cautious market environment.
Read full news article
Rossari Biotech Q4 FY26: Strong Quarter Masks Deeper Concerns
2026-04-28 15:01:27Rossari Biotech Ltd. delivered a robust fourth quarter performance for FY26, with consolidated net profit surging 40.28% quarter-on-quarter to ₹45.97 crores, marking the company's strongest quarterly profit to date. However, the celebratory numbers couldn't prevent a sharp 7.77% decline in the stock price to ₹466.80 following the results announcement, as investors grappled with deteriorating financial trends, mounting debt concerns, and sustained underperformance against both peers and broader market indices.
Read full news article
Rossari Biotech Ltd is Rated Sell
2026-04-25 10:10:25Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 Dec 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article






